A novel approach to specific allergy treatment: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 6642-6648

  Bohle, Barbara ^a   Breitwieser, Andreas ^b   Zwölfer, Bettina ^a   Jahn Schmid, Beatrice ^a   Sára, Margit ^b   Sleytr, Uwe B ^b   Ebner, Christof ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTAMINE; HYBRID PROTEIN; INTERLEUKIN 10; POLLEN ANTIGEN; RECOMBINANT BACTERIAL CELL SURFACE PROTEIN S BET V 1 ANTIGEN FUSION PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLERGENICITY; ALLERGY; ARTICLE; BACTERIAL CELL; BIRCH; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG EFFICACY; FEMALE; GENE SEQUENCE; GENETIC CODE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOTHERAPY; MALE; POLLEN; PRIORITY JOURNAL; TH2 CELL;

EID: 2442681742     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.6642     Document Type: Article

References (44)

1. Romagnani, S. 1998. The Th1/Th2 paradigm and allergic disorders. Allergy 53:12.
2. + T lymphocytes in atopic patients. J. Immunol. 144:4651.
3. Bousquet, J., R. Lockey, H. J. Malling, E. Alvarez-Cuesta, G. W. Canonica, M. D. Chapman, P. J. Creticos, J. M. Dayer, S. R. Durham, P. Demoly, et al. 1998. Allergen immunotherapy: therapeutic vaccines for allergic diseases: World Health Organization: American Academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 81:401.
4. Djurup, R. 1985. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy 40:469.
5. Lu, F. M., C. C. Chou, B. L. Chiang, and K. H. Hsieh. 1998. Immunologic changes during immunotherapy in asthmatic children: increased IL- 13 and allergen-specific IgG4 antibody levels. Ann. Allergy Asthma Immunol. 80:419.
6. Pierson-Mullany, L. K., D. Jackola, M. Blumenthal, and A. Rosenberg. 2000. Altered allergen binding capacities of Amb a 1-specific IgE and IgG4 from ragweed-sensitive patients receiving immunotherapy. Ann. Allergy Asthma Immunol. 84:241.
7. Jutel, M., W. J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U. R. Muller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154:4187.
8. Ebner, C., U. Siemann, B. Bohle, M. Willheim, U. Wiedermann, S. Schenk, F. Klotz, H. Ebner, D. Kraft, and O. Scheiner. 1997. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Ph1 p 1, a major grass pollen allergen. Clin. Exp. Allergy 27:1007.
9. Akdis, C. A., A. Joss, M. Akdis, and K. Blaser. 2001. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens. Int. Arch. Allergy Immunol. 124:180.
10. + T cells from allergic individuals. J. Exp. Med. 178:2123.
11. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J. Allergy Clin. Immunol. 97:1356.
12. Wiedermann, U., B. Jahn-Schmid, R. Fritsch, L. Bauer, H. Renz, D. Kraft, and C. Ebner. 1998. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin. Exp. Immunol. 111:144.
13. Valenta, R., and D. Kraft. 2002. From allergen structure to new forms of allergen-specific immunotherapy. Curr. Opin. Immunol. 14:718.
14. Bohle, B., B. Jahn-Schmid, D. Maurer, D. Kraft, and C. Ebner. 1999. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-81 and IFN-γ production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur. J. Immunol. 29:2344.
15. Bohle, B., L. Orel, D. Kraft, and C. Ebner. 2001. Oligodeoxynucleotides containing CpG motifs induce low levels of TNF-α in human B lymphocytes: possible adjuvants for Th1 responses. J. Immunol. 166:3743.
16. + T cells into Th1 effectors. J. Immunol. 163:5946.
17. Horner, A. A., G. F. Widhopf, J. A. Burger, K. Takabayashi, N. Cinman, A. Ronaghy, H. L. Spiegelberg, and E. Raz. 2001. Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells. J. Allergy Clin. Immunol. 108:417.
18. + T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J. Allergy Clin. Immunol. 108:815.
19. + TH2 lymphocytes into IFN-γ-producing cells. J. Allergy Clin. Immunol. 111:380.
20. Tighe, H., K. Takabayashi, D. Schwartz, G. Van Nest, S. Tuck, J. J. Eiden, A. Kagey-Sobotka, P. S. Creticos, L. M. Lichtenstein, H. L. Spiegelberg, and E. Raz. 2000. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J. Allergy Clin. Immunol. 106:124.
21. Marshall, J. D., S. Abtahi, J. J. Eiden, S. Tuck, R. Milley, F. Haycock, M. J. Reid, A. Kagey-Sobotka, P. S. Creticos, L. M. Lichtenstein, and G. Van Nest. 2001. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while down-regulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J. Allergy Clin. Immunol. 108:191.
22. Sleytr, U. B., M. Sara, D. Pum, B. Schuster, P. Messner, and C. Schäffer. 2003. Self assembly protein systems: microbial S-layers. In Biopolymers. A. Steinbüchel and S. Fahnestock, eds. Wiley-VCH, Weinheim, p 285.
23. Sara, M., and U. B. Sleytr. 2000. S-layer proteins. J. Bacteriol. 182:859.
24. Sleytr, U. B., P. Messner, D. Pum, and M. Sara. 1999. Crystalline bacterial cell surface layers (S-layers): from supramolecular cell structure to biomimetics and nanotechnology. Angew. Chem. Int. Ed. 38:1034.
25. Smith, R. H., P. Messner, L. R. Lamontagne, U. B. Sleytr, and F. M. Unger. 1993. Induction of T-cell immunity to oligosaccharide antigens immobilized on crystalline bacterial surface layers (S-layers). Vaccine 11:919.
26. Breitwieser, A., C. Mader, I. Schocher, K. Hoffmann-Sommergruber, W. Aberer, O. Scheiner, U. B. Sleytr, and M. Sara. 1998. A novel dipstick developed for rapid Bet v 1-specific IgE detection: recombinant allergen immobilized via a monoclonal antibody to crystalline bacterial cell-surface layers. Allergy 53:786.
27. Moll, D., C. Huber, B. Schlegel, D. Pum, U. B. Sleytr, and M. Sara. 2002. S-layer-streptavidin fusion proteins as template for nanopatterned molecular arrays. Proc. Natl. Acad. Sci. USA 99:14646.
28. Jahn-Schmid, B., M. Graninger, M. Glozik, S. Kupcu, C. Ebner, F. M. Unger, U. B. Sleytr, and P. Messner. 1996. Immunoreactivity of allergen (Bet v 1) conjugated to crystalline bacterial cell surface layers (S-layers). Immunotechnology 2:103.
29. Jahn-Schmid, B., P. Messner, F. M. Unger, U. B. Sleytr, O. Scheiner, and D. Kraft. 1996. Toward selective elicitation of TH1-controlled vaccination responses: vaccine applications of bacterial surface layer proteins. J. Biotechnol. 44:225.
30. Jahn-Schmid, B., U. Siemann, A. Zenker, B. Bohle, P. Messner, F. M. Unger, U. B. Sleytr, O. Scheiner, D. Kraft, and C. Ebner. 1997. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12. Int. Immunol. 9:1867.
31. Jarosch, M., E. M. Egelseer, D. Mattanovich, U. B. Sleytr, and M. Sara. 2000. S-layer gene sbsC of Bacillus stearothermophilus ATCC 12980: molecular characterization and heterologous expression in Escherichia coli. Microbiology 146:273.
32. Jarosch, M., E. M. Egelseer, C. Huber, D. Moll, D. Mattanovich, U. B. Sleytr, and M. Sara. 2001. Analysis of the structure-function relationship of the S-layer protein SbsC of Bacillus stearothermophilus ATCC 12980 by producing truncated forms. Microbiology 147:1353.
33. Breitwieser, A., E. M. Egelseer, D. Moll, N. Ilk, C. Hotzy, B. Bohle, C. Ebner, U. B. Sleytr, and M. Sara. 2002. A recombinant bacterial cell surface (S-layer)-major birch pollen allergen-fusion protein (rSbsC/Bet v 1) maintains the ability to self-assemble into regularly structured monomolecular lattices and the functionality of the allergen. Protein Eng. 15:243.
34. Ebner, C., Z. Szepfalusi, F. Ferreira, A. Jilek, R. Valenta, P. Parronchi, E. Maggi, S. Romagnani, O. Scheiner, and D. Kraft. 1993. Identification of multiple T cell epitopes on Bet v 1, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J. Immunol. 150:1047.
35. Ebner, C., S. Schenk, Z. Szepfalusi, K. Hoffmann, F. Ferreira, M. Willheim, O. Scheiner, and D. Kraft. 1993. Multiple T cell specificities for Bet v 1, the major birch pollen allergen, within single individuals: studies using specific T cell clones and overlapping peptides. Eur. J. Immunol. 23:1523.
36. + T cells. J. Exp. Med. 184:19.
37. Akdis, C. A., and K. Blaser. 2001. Mechanisms of interleukin-10-mediated immune suppression. Immunology 103:131.
38. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:5530.
39. Cottrez, F., S. D. Hurst, R. L. Coffman, and H. Groux. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:4848.
40. + T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111:1255.
41. Jutel, M., M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, K. Blaser, and C. A. Akdis. 2003. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33:1205.
42. Akdis, C. A., T. Blesken, M. Akdis, S. S. Alkan, B. Wuthrich, C. H. Heusser, and K. Blaser. 1997. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol. 99:345.
43. Carballido, J. M., N. Carballido-Perrig, A. Oberli-Schrammli, C. H. Heusser, and K. Blaser. 1994. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro. J. Allergy Clin. Immunol. 93:758.
44. Jeannin, P., S. Lecoanet, Y. Delneste, J. F. Gauchat, and J. Y. Bonnefoy. 1998. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 160:3555.